L. Tsironis

发表

Lipoprotein (a) levels and apolipoprotein (a) isoform size in patients with subclinical hypothyroidism: effect of treatment with levothyroxine.

A. Tsatsoulis, H. Milionis, M. Elisaf, 2003, Thyroid : official journal of the American Thyroid Association.

Short- and long-term elevation of autoantibody titers against oxidized LDL in patients with acute coronary syndromes. Role of the lipoprotein-associated phospholipase A2 and the effect of atorvastatin treatment.

J. Goudevenos, A. Tselepis, L. Tsironis, 2008, Atherosclerosis.

In Atherosclerosis and Cardiovascular Disease 2 Phospholipase a New Insights into the Role of Lipoprotein(a)-associated Lipoprotein-associated

S. Tsimikas, A. Tselepis, L. Tsironis, 2022 .

New Insights Into the Role of Lipoprotein(a)-Associated Lipoprotein-Associated Phospholipase A2 in Atherosclerosis and Cardiovascular Disease

S. Tsimikas, A. Tselepis, L. Tsironis, 2007, Arteriosclerosis, thrombosis, and vascular biology.

Effect of a Synthetic Peptide Corresponding to Residues 313 to 320 of the αIIb Subunit of the Human Platelet Integrin αIIbβ3 on Carotid Artery Thrombosis in Rabbits

A. Kotsia, L. Michalis, C. Katsouras, 2009, Journal of Pharmacology and Experimental Therapeutics.

Autoantibody titers against OxLDL are correlated with Achilles tendon thickness in patients with familial hypercholesterolemia Published, JLR Papers in Press, August 3, 2006.

M. Argyropoulou, M. Elisaf, D. Kiortsis, 2006, Journal of Lipid Research.

Serum Lipoprotein(a) Concentrations and Apolipoprotein(a) Isoforms: Association with the Severity of Clinical Presentation in Patients with Coronary Heart Disease

J. Goudevenos, M. Elisaf, L. Michalis, 2001, Journal of cardiovascular risk.

Lipoprotein(a)-Associated PAF-Acetylhydrolase Activity in Patients with Coronary Artery Disease

J. Goudevenos, M. Elisaf, C. Katsouras, 2003 .

Lipoprotein(a) as a cardiovascular risk factor.

L. Michalis, M. Elisaf, C. Katsouras, 2005, Future cardiology.

Effect of lipoprotein (a) on platelet activation induced by platelet-activating factor: role of apolipoprotein (a) and endogenous PAF-acetylhydrolase.

H. Milionis, M. Elisaf, A. Tselepis, 2004, Cardiovascular research.

Reduced PAF-acetylhydrolase activity associated with Lp(a) in patients with coronary artery disease.

J. Goudevenos, M. Elisaf, C. Katsouras, 2004, Atherosclerosis.

Investigation of the role of adjacent amino acids to the 313–320 sequence of the αIIb subunit on platelet activation and fibrinogen binding to αIIbβ3

V. Tsikaris, A. Tselepis, L. Tsironis, 2006 .

Use of ionic liquids as media for the biocatalytic preparation of flavonoid derivatives with antioxidant potency.

A. Polydera, H. Stamatis, A. Tselepis, 2006, Journal of biotechnology.

Antibiotic prescriptions in primary health care in a rural population in Crete, Greece

I. Tsiligianni, L. Tsironis, Polyvios Papadokostakis, 2011, BMC Research Notes.

Efficient enzymatic preparation of hydroxycinnamates in ionic liquids enhances their antioxidant effect on lipoproteins oxidative modification.

A. Polydera, H. Stamatis, A. Tselepis, 2009, New biotechnology.

Platelet-derived microparticles bind to low-density lipoprotein (LDL) in human plasma and reduce its susceptibility to oxidation

A. Tselepis, L. Tsironis, J. Mitsios, 2016 .

Atherosclerosis and Cardiovascular Disease

Antonio Gaddi, G. C. Descovich, S. Tsimikas, 1990, Springer Netherlands.